The following is Syngenta's formal statement this afternoon regarding the outcome of the jury's decision in the Viptera state-wide, federal class-action trial in Kansas City, Kansas.
"We are disappointed with today’s verdict because it will only serve to deny American farmers access to future technologies even when they are fully approved in the U.S. The case is without merit and we will move forward with an appeal and continue to defend the rights of American farmers to access safe and effective U.S.- approved technologies.
"Syngenta commercialized Agrisure Viptera in full compliance with U.S. regulatory and legal requirements, including USDA, EPA, and FDA regulations. Viptera had also received approval in the key import markets recommended at the time by the National Corn Growers Association (NCGA) and other industry associations.
"Syngenta believes that American farmers should have access to the latest U.S.-approved technology to help them increase their productivity and yield. American farmers shouldn’t have to rely on a foreign government to decide what products they can use on their farms."
The company shares more information pretaining to the litigation at www.vipterachinafacts.com.